Wouter P. te Rijdt

1.1k citations

17 papers · 348 indexed · h-index 10

Cardiology and Cardiovascular Medicine top 10%
Molecular Biology
Orthopedics and Sports Medicine top 10%
Surgery
Cell Biology

Co-authors: J. Peter van Tintelen Rudolf A. de Boer Maarten P. van den Berg Edgar T. Hoorntje Cristina Basso Albert J.H. Suurmeijer Aryan Vink Daniel P. Judge
Topics: Cardiomyopathy and Myosin Studies (15 papers)Cardiovascular Effects of Exercise (11 papers)Viral Infections and Immunology Research (5 papers)
Cited by: Cardiology and Cardiovascular Medicine Orthopedics and Sports Medicine Molecular Biology
Journals: PLoS ONE Scientific Reports European Heart Journal
Partner nations: Netherlands United Kingdom Italy

In The Last Decade

Wouter P. te Rijdt

14 papers receiving 342 citations

Peers

Countries citing papers authored by Wouter P. te Rijdt

Since Specialization

Citations

This map shows the geographic impact of Wouter P. te Rijdt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter P. te Rijdt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter P. te Rijdt more than expected).

Fields of papers citing papers by Wouter P. te Rijdt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wouter P. te Rijdt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter P. te Rijdt. The network helps show where Wouter P. te Rijdt may publish in the future.

Co-authorship network of co-authors of Wouter P. te Rijdt

This figure shows the co-authorship network connecting the top 25 collaborators of Wouter P. te Rijdt. A scholar is included among the top collaborators of Wouter P. te Rijdt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wouter P. te Rijdt. Wouter P. te Rijdt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Assessing the psychometric properties of generic (EQ-5D-5L) and disease-specific (KCCQ) quality of life in patients with hypertrophic cardiomyopathy in the AFFECT-HCM study 2025 ·Open Heart ·(unknown),(unknown),Rudolf A. de Boer,Silvia Evers,Tjeerd Germans,Alexander Hirsch,Christian Knackstedt,Wouter P. te Rijdt,Marjon A. van Slegtenhorst,Arend F. L. Schinkel,Peter-Paul Zwetsloot,Michelle Michels,Mickaël Hiligsmann	0
2	High incidence of malignant arrhythmias and heart failure in patients with RBM20-associated cardiomyopathy: A multicenter cohort study and review of the literature 2025 ·International Journal of Cardiology ·(unknown),Wouter P. te Rijdt,Ahmad S. Amin,Déborah Morris-Rosendahl,Alexander Hirsch,Yael Ben‐Haim,Arjan C. Houweling,Amanda Varnava,Elijah R. Behr,(unknown),(unknown),(unknown),Jan H. von der Thüsen,Michelle Michels,Rudolf A. de Boer,Marjon A. van Slegtenhorst,Kadir Çalişkan	0
3	Epigenetics of cardiomyopathies: the next frontier 2024 ·Heart Failure Reviews ·(unknown),(unknown),Wouter P. te Rijdt,(unknown),Wouter C. Meijers,Kadir Çalişkan	2
4	Malignant arrhythmias and advanced heart failure in patients with RBM20 cardiomyopathy: a single center cohort study and review of the literature 2023 ·European Heart Journal ·(unknown),Wouter P. te Rijdt,(unknown),Kadir Çalişkan	0
5	P62‐positive aggregates are homogenously distributed in the myocardium and associated with the type of mutation in genetic cardiomyopathy 2021 ·Journal of Cellular and Molecular Medicine ·(unknown),(unknown),Dennis Dooijes,Wouter P. te Rijdt,(unknown),(unknown),(unknown),Magdaléna Harakaľová,Roel Goldschmeding,Albert J.H. Suurmeijer,Folkert W. Asselbergs,Aryan Vink	6
6	Optimal echocardiographic assessment of myocardial dysfunction for arrhythmic risk stratification in phospholamban mutation carriers 2021 ·European Heart Journal - Cardiovascular Imaging ·Karim Taha,Tom E. Verstraelen,Remco de Brouwer,Rianne H.A.C.M. de Bruin‐Bon,Maarten J. Cramer,Wouter P. te Rijdt,Berto J. Bouma,Rudolf A. de Boer,Pieter A. Doevendans,Folkert W. Asselbergs,Arthur A.M. Wilde,Maarten P. van den Berg,Arco J. Teske	3
7	Early Mechanical Alterations in Phospholamban Mutation Carriers 2020 ·JACC. Cardiovascular imaging ·Karim Taha,Wouter P. te Rijdt,Tom E. Verstraelen,Maarten J. Cramer,Rudolf A. de Boer,Rianne H.A.C.M. de Bruin‐Bon,Berto J. Bouma,Folkert W. Asselbergs,Arthur A.M. Wilde,Maarten P. van den Berg,Arco J. Teske	13
8	The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy 2020 ·Scientific Reports ·Tim R. Eijgenraam,Bastiaan J. Boukens,Cornelis J. Boogerd,Elisabeth M. Schouten,(unknown),(unknown),Wouter P. te Rijdt,Edgar T. Hoorntje,Paul A. van der Zwaag,Eva van Rooij,J. Peter van Tintelen,Maarten P. van den Berg,Peter van der Meer,Jolanda van der Velden,Herman H.W. Silljé,Rudolf A. de Boer	42
9	Desmin is essential for the structure and function of the sinoatrial node: implications for increased arrhythmogenesis 2020 ·American Journal of Physiology-Heart and Circulatory Physiology ·Manolis Mavroidis,(unknown),Pavlos Rigas,(unknown),Ismini Kloukina,Wouter P. te Rijdt,Nikolaos Kavantzas,(unknown),J. Peter van Tintelen,Irini Skaliora,Constantinos H. Davos	16
10	1041 Early detection of biventricular mechanical dysfunction in PLN R14del mutation carriers 2020 ·European Heart Journal - Cardiovascular Imaging ·Karim Taha,Wouter P. te Rijdt,(unknown),Maarten J. Cramer,Folkert W. Asselbergs,Berto J. Bouma,Maarten P. van den Berg,Arco J. Teske	1
11	Distinct molecular signature of phospholamban p.Arg14del arrhythmogenic cardiomyopathy 2018 ·Cardiovascular Pathology ·Wouter P. te Rijdt,Angeliki Asimaki,Jan D.H. Jongbloed,Edgar T. Hoorntje,Elisabetta Lazzarini,Paul A. van der Zwaag,Rudolf A. de Boer,J. Peter van Tintelen,Jeffrey E. Saffitz,Maarten P. van den Berg,Albert J.H. Suurmeijer	15
12	Myocardial fibrosis as an early feature in phospholamban p.Arg14del mutation carriers: phenotypic insights from cardiovascular magnetic resonance imaging 2018 ·European Heart Journal - Cardiovascular Imaging ·Wouter P. te Rijdt,(unknown),Thomas M. Gorter,Paul A. van der Zwaag,(unknown),S. Matthijs Boekholdt,J. Peter van Tintelen,Paul L. van Haelst,R. Nils Planken,Rudolf A. de Boer,Albert J.H. Suurmeijer,Dirk J. van Veldhuisen,Arthur A.M. Wilde,Tineke P. Willems,Pascal F.H.M. van Dessel,Maarten P. van den Berg	40
13	Phospholamban immunostaining is a highly sensitive and specific method for diagnosing phospholamban p.Arg14del cardiomyopathy 2017 ·Cardiovascular Pathology ·Wouter P. te Rijdt,(unknown),Edgar T. Hoorntje,Jan D.H. Jongbloed,Paul A. van der Zwaag,Folkert W. Asselbergs,Dennis Dooijes,Rudolf A. de Boer,J. Peter van Tintelen,Maarten P. van den Berg,Aryan Vink,Albert J.H. Suurmeijer	16
14	Arrhythmogenic cardiomyopathy: pathology, genetics, and concepts in pathogenesis 2017 ·Cardiovascular Research ·Edgar T. Hoorntje,Wouter P. te Rijdt,Cynthia A. James,Kalliopi Pilichou,Cristina Basso,Daniel P. Judge,Connie R. Bezzina,J. Peter van Tintelen	83
15	Phospholamban p.Arg14del cardiomyopathy is characterized by phospholamban aggregates, aggresomes, and autophagic degradation 2016 ·Histopathology ·Wouter P. te Rijdt,J. Peter van Tintelen,Aryan Vink,Allard C. van der Wal,Rudolf A. de Boer,Maarten P. van den Berg,Albert J.H. Suurmeijer	46
16	High Resolution Systematic Digital Histological Quantification of Cardiac Fibrosis and Adipose Tissue in Phospholamban p.Arg14del Mutation Associated Cardiomyopathy 2014 ·PLoS ONE ·Johannes M.I.H. Gho,René van Es,Nikolas Stathonikos,Magdaléna Harakaľová,Wouter P. te Rijdt,Albert J.H. Suurmeijer,Jeroen F. van der Heijden,Nicolaas de Jonge,Steven A. J. Chamuleau,Roel A. de Weger,Folkert W. Asselbergs,Aryan Vink	28
17	Clinical utility gene card for: arrhythmogenic right ventricular cardiomyopathy (ARVC) 2013 ·European Journal of Human Genetics ·Wouter P. te Rijdt,Jan D.H. Jongbloed,Rudolf A. de Boer,Gaetano Thiene,Cristina Basso,Maarten P. van den Berg,J. Peter van Tintelen	37

About Wouter P. te Rijdt

Wouter P. te Rijdt is a scholar working on Cardiology and Cardiovascular Medicine, Orthopedics and Sports Medicine and Molecular Biology, having authored 17 papers that have together received 348 indexed citations. Recurring topics across this work include Cardiomyopathy and Myosin Studies (15 papers), Cardiovascular Effects of Exercise (11 papers) and Viral Infections and Immunology Research (5 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (299 citations), Orthopedics and Sports Medicine (47 citations) and Molecular Biology (85 citations). Wouter P. te Rijdt has collaborated with scholars based in Netherlands, United Kingdom and Italy. Frequent co-authors include J. Peter van Tintelen, Rudolf A. de Boer, Maarten P. van den Berg, Edgar T. Hoorntje, Cristina Basso, Albert J.H. Suurmeijer, Aryan Vink, Daniel P. Judge, Kalliopi Pilichou and Connie R. Bezzina. Their work appears in journals such as PLoS ONE, Scientific Reports and European Heart Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact